Matrix proteins of Nipah and Hendra viruses interact with beta subunits of AP-3 complexes

Journal of Virology

Volumn 88, Issue 22, 2014, Pages 13099-13110

  Sun, Weina ^a   McCrory, Thomas S ^a   Khaw, Wei Young ^a   Petzing, Stephanie ^b   Myers, Terrell ^a   Schmitt, Anthony P ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AP3B1 PROTEIN; BINDING PROTEIN; M PROTEIN; MATRIX PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; ADAPTOR PROTEIN; AP3B1 PROTEIN, HUMAN; BETA ADAPTIN;

ANIMAL CELL; ARTICLE; BAT; BETA CHAIN; COMPLEX FORMATION; CONTROLLED STUDY; GENE OVEREXPRESSION; HENDRA VIRUS; IMMUNOPRECIPITATION; MASS SPECTROMETRY; NIPAH VIRUS; NONHUMAN; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION; PTEROPUS ALECTO; VIROGENESIS; VIRUS IDENTIFICATION; VIRUS LIKE AGENT; HOST PATHOGEN INTERACTION; HUMAN; METABOLISM; PHYSIOLOGY; PROTEIN ANALYSIS; VIRUS RELEASE;

ADAPTOR PROTEIN COMPLEX 3; ADAPTOR PROTEIN COMPLEX BETA SUBUNITS; HENDRA VIRUS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNOPRECIPITATION; MASS SPECTROMETRY; NIPAH VIRUS; PROTEIN INTERACTION MAPPING; VIRAL MATRIX PROTEINS; VIRUS RELEASE;

EID: 84908377016     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02103-14     Document Type: Article

References (60)

1. Eaton BT, Broder CC, Middleton D, Wang LF. 2006. Hendra and Nipah viruses: different and dangerous. Nat. Rev. Microbiol. 4:23-35. http://dx.doi.org/10.1038/nrmicro1323.
2. Bishop KA, Broder CC. 2008. Hendra and Nipah viruses: lethal zoonotic paramyxoviruses, p 155-187. In Scheld WM, Hammer SM, Hughes JM (ed), Emerging infections. ASM Press, Washington, DC.
3. Ksiazek TG, Rota PA, Rollin PE. 2011. A review of Nipah and Hendra viruses with an historical aside. Virus Res. 162:173-183. http://dx.doi.org/10.1016/j.virusres.2011.09.026.
4. Halpin K, Hyatt AD, Fogarty R, Middleton D, Bingham J, Epstein JH, Rahman SA, Hughes T, Smith C, Field HE, Daszak P, Henipavirus Ecology Research Group. 2011. Pteropid bats are confirmed as the reservoir hosts of henipaviruses: a comprehensive experimental study of virus transmission. Am. J. Trop. Med. Hyg. 85:946-951. http://dx.doi.org/10.4269/ajtmh.2011.10-0567.
5. Clayton BA, Wang LF, Marsh GA. 2013. Henipaviruses: an updated review focusing on the pteropid reservoir and features of transmission. Zoonoses Public Health 60:69-83. http://dx.doi.org/10.1111/j.1863-2378.2012.01501.x.
6. O'Sullivan JD, Allworth AM, Paterson DL, Snow TM, Boots R, Gleeson LJ, Gould AR, Hyatt AD, Bradfield J. 1997. Fatal encephalitis due to novel paramyxovirus transmitted from horses. Lancet 349:93-95. http://dx.doi.org/10.1016/S0140-6736(96)06162-4.
7. Wong KT, Robertson T, Ong BB, Chong JW, Yaiw KC, Wang LF, Ansford AJ, Tannenberg A. 2009. Human Hendra virus infection causes acute and relapsing encephalitis. Neuropathol. Appl. Neurobiol. 35:296-305. http://dx.doi.org/10.1111/j.1365-2990.2008.00991.x.
8. Playford EG, McCall B, Smith G, Slinko V, Allen G, Smith I, Moore F, Taylor C, Kung YH, Field H. 2010. Human Hendra virus encephalitis associated with equine outbreak, Australia, 2008. Emerg. Infect. Dis. 16: 219-223. http://dx.doi.org/10.3201/eid1602.090552.
9. Aljofan M. 2013. Hendra and Nipah infection: emerging paramyxoviruses. Virus Res. 177:119-126. http://dx.doi.org/10.1016/j.virusres.2013.08.002.
10. Chua KB, Bellini WJ, Rota PA, Harcourt BH, Tamin A, Lam SK, Ksiazek TG, Rollin PE, Zaki SR, Shieh W, Goldsmith CS, Gubler DJ, Roehrig JT, Eaton B, Gould AR, Olson J, Field H, Daniels P, Ling AE, Peters CJ, Anderson LJ, Mahy BW. 2000. Nipah virus: a recently emergent deadly paramyxovirus. Science 288:1432-1435. http://dx.doi.org/10.1126/science.288.5470.1432.
11. Liljeroos L, Butcher SJ. 2013. Matrix proteins as centralized organizers of negative-sense RNA virions. Front. Biosci. (Landmark Ed.) 18:696-715. http://dx.doi.org/10.2741/4132.
12. Takimoto T, Portner A. 2004. Molecular mechanism of paramyxovirus budding. Virus Res. 106:133-145. http://dx.doi.org/10.1016/j.virusres.2004.08.010.
13. Harrison MS, Sakaguchi T, Schmitt AP. 2010. Paramyxovirus assembly and budding: building particles that transmit infections. Int. J. Biochem. Cell Biol. 42:1416-1429. http://dx.doi.org/10.1016/j.biocel.2010.04.005.
14. Takimoto T, Murti KG, Bousse T, Scroggs RA, Portner A. 2001. Role of matrix and fusion proteins in budding of Sendai virus. J. Virol. 75:11384-11391. http://dx.doi.org/10.1128/JVI.75.23.11384-11391.2001.
15. Sugahara F, Uchiyama T, Watanabe H, Shimazu Y, Kuwayama M, Fujii Y, Kiyotani K, Adachi A, Kohno N, Yoshida T, Sakaguchi T. 2004. Paramyxovirus Sendai virus-like particle formation by expression of multiple viral proteins and acceleration of its release by C protein. Virology 325:1-10. http://dx.doi.org/10.1016/j.virol.2004.04.019.
16. Coronel EC, Murti KG, Takimoto T, Portner A. 1999. Human parainfluenza virus type 1 matrix and nucleoprotein genes transiently expressed in mammalian cells induce the release of virus-like particles containing nucleocapsid-like structures. J. Virol. 73:7035-7038.
17. Pantua HD, McGinnes LW, Peeples ME, Morrison TG. 2006. Require-ments for the assembly and release of Newcastle disease virus-like particles. J. Virol. 80:11062-11073. http://dx.doi.org/10.1128/JVI.00726-06.
18. Pohl C, Duprex WP, Krohne G, Rima BK, Schneider-Schaulies S. 2007. Measles virus M and F proteins associate with detergent-resistant membrane fractions and promote formation of virus-like particles. J. Gen. Virol. 88:1243-1250. http://dx.doi.org/10.1099/vir.0.82578-0.
19. Runkler N, Pohl C, Schneider-Schaulies S, Klenk HD, Maisner A. 2007. Measles virus nucleocapsid transport to the plasma membrane requires stable expression and surface accumulation of the viral matrix protein. Cell. Microbiol. 9:1203-1214. http://dx.doi.org/10.1111/j.1462-5822.2006.00860.x.
20. Ciancanelli MJ, Basler CF. 2006. Mutation of YMYL in the Nipah virus matrix protein abrogates budding and alters subcellular localization. J. Virol. 80:12070-12078. http://dx.doi.org/10.1128/JVI.01743-06.
21. Patch JR, Crameri G, Wang LF, Eaton BT, Broder CC. 2007. Quantitative analysis of Nipah virus proteins released as virus-like particles reveals central role for the matrix protein. Virol. J. 4:1. http://dx.doi.org/10.1186/1743-422X-4-1.
22. Patch JR, Han Z, McCarthy SE, Yan L, Wang LF, Harty RN, Broder CC. 2008. The YPLGVG sequence of the Nipah virus matrix protein is required for budding. Virol. J. 5:137. http://dx.doi.org/10.1186/1743-422X-5-137.
23. Schmitt AP, Leser GP, Waning DL, Lamb RA. 2002. Requirements for budding of paramyxovirus simian virus 5 virus-like particles. J. Virol. 76:3952-3964. http://dx.doi.org/10.1128/JVI.76.8.3952-3964.2002.
24. Li M, Schmitt PT, Li Z, McCrory TS, He B, Schmitt AP. 2009. Mumps virus matrix, fusion, and nucleocapsid proteins cooperate for efficient production of virus-like particles. J. Virol. 83:7261-7272. http://dx.doi.org/10.1128/JVI.00421-09.
25. Harrison MS, Sakaguchi T, Schmitt AP. 2011. Paramyxovirus budding mechanisms, p 193-218. In Luo M (ed), Negative strand RNA virus. World Scientific, Hackensack, NJ.
26. Lyles DS. 2013. Assembly and budding of negative-strand RNA viruses. Adv. Virus Res. 85:57-90. http://dx.doi.org/10.1016/B978-0-12-408116-1.00003-3.
27. Rossman JS, Lamb RA. 2013. Viral membrane scission. Annu. Rev. Cell Dev. Biol. 29:551-569. http://dx.doi.org/10.1146/annurev-cellbio-101011-155838.
28. Votteler J, Sundquist WI. 2013. Virus budding and the ESCRT pathway. Cell Host Microbe 14:232-241. http://dx.doi.org/10.1016/j.chom.2013.08.012.
29. Niwa H, Yamamura K, Miyazaki J. 1991. Efficient selection for highexpression transfectants with a novel eukaryotic vector. Gene 108:193-199. http://dx.doi.org/10.1016/0378-1119(91)90434-D.
30. Flicek P, Amode MR, Barrell D, Beal K, Billis K, Brent S, Carvalho-Silva D, Clapham P, Coates G, Fitzgerald S, Gil L, Giron CG, Gordon L, Hourlier T, Hunt S, Johnson N, Juettemann T, Kahari AK, Keenan S, Kulesha E, Martin FJ, Maurel T, McLaren WM, Murphy DN, Nag R, Overduin B, Pignatelli M, Pritchard B, Pritchard E, Riat HS, Ruffier M, Sheppard D, Taylor K, Thormann A, Trevanion SJ, Vullo A, Wilder SP, Wilson M, Zadissa A, Aken BL, Birney E, Cunningham F, Harrow J, Herrero J, Hubbard TJ, Kinsella R, Muffato M, Parker A, Spudich G, Yates A, Zerbino DR, Searle SM. 2014. Ensembl 2014. Nucleic Acids Res. 42:D749-D755. http://dx.doi.org/10.1093/nar/gkt1196.
31. Larkin MA, Blackshields G, Brown NP, Chenna R, McGettigan PA, McWilliam H, Valentin F, Wallace IM, Wilm A, Lopez R, Thompson JD, Gibson TJ, Higgins DG. 2007. Clustal W and Clustal X version 2.0. Bioinformatics 23:2947-2948. http://dx.doi.org/10.1093/bioinformatics/btm404.
32. Pei Z, Bai Y, Schmitt AP. 2010. PIV5 M protein interaction with host protein angiomotin-like 1. Virology 397:155-166. http://dx.doi.org/10.1016/j.virol.2009.11.002.
33. Pei Z, Harrison MS, Schmitt AP. 2011. Parainfluenza virus 5 m protein interaction with host protein 14-3-3 negatively affects virus particle formation. J. Virol. 85:2050-2059. http://dx.doi.org/10.1128/JVI.02111-10.
34. Schmitt PT, Ray G, Schmitt AP. 2010. The C-terminal end of parainfluenza virus 5 NP protein is important for virus-like particle production and M-NP protein interaction. J. Virol. 84:12810-12823. http://dx.doi.org/10.1128/JVI.01885-10.
35. Harrison MS, Schmitt PT, Pei Z, Schmitt AP. 2012. Role of ubiquitin in parainfluenza virus 5 particle formation. J. Virol. 86:3474-3485. http://dx.doi.org/10.1128/JVI.06021-11.
36. Rodriguez L, Cuesta I, Asenjo A, Villanueva N. 2004. Human respiratory syncytial virus matrix protein is an RNA-binding protein: binding properties, location and identity of the RNA contact residues. J. Gen. Virol. 85:709-719. http://dx.doi.org/10.1099/vir.0.19707-0.
37. Gomis-Ruth FX, Dessen A, Timmins J, Bracher A, Kolesnikowa L, Becker S, Klenk HD, Weissenhorn W. 2003. The matrix protein VP40 from Ebola virus octamerizes into pore-like structures with specific RNA binding properties. Structure 11:423-433. http://dx.doi.org/10.1016/S0969-2126(03)00050-9.
38. Wakefield L, Brownlee GG. 1989. RNA-binding properties of influenza A virus matrix protein M1. Nucleic Acids Res. 17:8569-8580. http://dx.doi.org/10.1093/nar/17.21.8569.
39. Newell-Litwa K, Seong E, Burmeister M, Faundez V. 2007. Neuronal and non-neuronal functions of the AP-3 sorting machinery. J. Cell Sci. 120:531-541. http://dx.doi.org/10.1242/jcs.03365.
40. Peden AA, Oorschot V, Hesser BA, Austin CD, Scheller RH, Klumperman J. 2004. Localization of the AP-3 adaptor complex defines a novel endosomal exit site for lysosomal membrane proteins. J. Cell Biol. 164: 1065-1076. http://dx.doi.org/10.1083/jcb.200311064.
41. Dell'Angelica EC, Ooi CE, Bonifacino JS. 1997. Beta3A-adaptin, a subunit of the adaptor-like complex AP-3. J. Biol. Chem. 272:15078-15084. http://dx.doi.org/10.1074/jbc.272.24.15078.
42. Dong X, Li H, Derdowski A, Ding L, Burnett A, Chen X, Peters TR, Dermody TS, Woodruff E, Wang JJ, Spearman P. 2005. AP-3 directs the intracellular trafficking of HIV-1 Gag and plays a key role in particle assembly. Cell 120:663-674. http://dx.doi.org/10.1016/j.cell.2004.12.023.
43. Garcia E, Nikolic DS, Piguet V. 2008. HIV-1 replication in dendritic cells occurs through a tetraspanin-containing compartment enriched in AP-3. Traffic 9:200-214. http://dx.doi.org/10.1111/j.1600-0854.2007.00678.x.
44. Liu L, Sutton J, Woodruff E, Villalta F, Spearman P, Dong X. 2012. Defective HIV-1 particle assembly in AP-3-deficient cells derived from patients with Hermansky-Pudlak syndrome type 2. J. Virol. 86:11242-11253. http://dx.doi.org/10.1128/JVI.00544-12.
45. Azevedo C, Burton A, Ruiz-Mateos E, Marsh M, Saiardi A. 2009. Inositol pyrophosphate mediated pyrophosphorylation of AP3B1 regulates HIV-1 Gag release. Proc. Natl. Acad. Sci. U. S. A. 106:21161-21166. http://dx.doi.org/10.1073/pnas.0909176106.
46. Demirov DG, Ono A, Orenstein JM, Freed EO. 2002. Overexpression of the N-terminal domain of TSG101 inhibits HIV-1 budding by blocking late domain function. Proc. Natl. Acad. Sci. U. S. A. 99:955-960. http://dx.doi.org/10.1073/pnas.032511899.
47. Freed EO. 2003. The HIV-TSG101 interface: recent advances in a budding field. Trends Microbiol. 11:56-59. http://dx.doi.org/10.1016/S0966-842X(02)00013-6.
48. Chen C, Vincent O, Jin J, Weisz OA, Montelaro RC. 2005. Functions of early (AP-2) and late (AIP1/ALIX) endocytic proteins in equine infectious anemia virus budding. J. Biol. Chem. 280:40474-40480. http://dx.doi.org/10.1074/jbc.M509317200.
49. Fujii K, Hurley JH, Freed EO. 2007. Beyond Tsg101: the role of Alix in 'ESCRTing' HIV-1. Nat. Rev. Microbiol. 5:912-916. http://dx.doi.org/10.1038/nrmicro1790.
50. Martin-Serrano J, Yarovoy A, Perez-Caballero D, Bieniasz PD. 2003. Divergent retroviral late-budding domains recruit vacuolar protein sorting factors by using alternative adaptor proteins. Proc. Natl. Acad. Sci. U. S. A. 100:12414-12419. http://dx.doi.org/10.1073/pnas.2133846100.
51. Munshi UM, Kim J, Nagashima K, Hurley JH, Freed EO. 2007. An Alix fragment potently inhibits HIV-1 budding: characterization of binding to retroviral YPXL late domains. J. Biol. Chem. 282:3847-3855. http://dx.doi.org/10.1074/jbc.M607489200.
52. Wang YE, Park A, Lake M, Pentecost M, Torres B, Yun TE, Wolf MC, Holbrook MR, Freiberg AN, Lee B. 2010. Ubiquitin-regulated nuclearcytoplasmic trafficking of the Nipah virus matrix protein is important for viral budding. PLoS Pathog. 6:e1001186. http://dx.doi.org/10.1371/journal.ppat.1001186.
53. Robinson MS, Bonifacino JS. 2001. Adaptor-related proteins. Curr. Opin. Cell Biol. 13:444-453. http://dx.doi.org/10.1016/S0955-0674(00) 00235-0.
54. Dell'Angelica EC. 2009. AP-3-dependent trafficking and disease: the first decade. Curr. Opin. Cell Biol. 21:552-559. http://dx.doi.org/10.1016/j.ceb.2009.04.014.
55. Kyere SK, Mercredi PY, Dong X, Spearman P, Summers MF. 2012. The HIV-1 matrix protein does not interact directly with the protein interactive domain of AP-3delta. Virus Res. 169:411-414. http://dx.doi.org/10.1016/j.virusres.2012.06.007.
56. Ivan V, Martinez-Sanchez E, Sima LE, Oorschot V, Klumperman J, Petrescu SM, van der Sluijs P. 2012. AP-3 and Rabip4' coordinately regulate spatial distribution of lysosomes. PLoS One 7:e48142. http://dx.doi.org/10.1371/journal.pone.0048142.
57. Harty RN. 2009. No exit: targeting the budding process to inhibit filovirus replication. Antiviral Res. 81:189-197. http://dx.doi.org/10.1016/j.antiviral.2008.12.003.
58. Tavassoli A, Lu Q, Gam J, Pan H, Benkovic SJ, Cohen SN. 2008. Inhibition of HIV budding by a genetically selected cyclic peptide targeting the Gag-TSG101 interaction. ACS Chem. Biol. 3:757-764. http://dx.doi.org/10.1021/cb800193n.
59. Waheed AA, Freed EO. 2008. Peptide inhibitors of HIV-1 egress. ACS Chem. Biol. 3:745-747. http://dx.doi.org/10.1021/cb800296j.
60. Han Z, Lu J, Liu Y, Davis B, Lee MS, Olson MA, Ruthel G, Freedman BD, Schnell MJ, Wrobel JE, Reitz AB, Harty RN. 2014. Small molecule probes targeting the viral PPxY-host Nedd4 interface block egress of a broad range of RNA viruses. J. Virol. 88:7294-7306. http://dx.doi.org/10.1128/JVI.00591-14.